The largest database of trusted experimental protocols

9 protocols using qiaamp dsp viral rna mini kit

1

MERS-CoV Detection by rRT-PCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was extracted from clinical specimens using either a QIAamp DSP Viral RNA Mini Kit (Catalog No. 61904, QIAGEN GmbH) or an automated MagNAPure 96 extraction instrument with a total nucleic acid isolation kit (Roche). The extraction was performed according to the manufacturers’ instructions and the extracted RNA was stored at −70°C.
MERS-CoVs were detected in specimens using real-time reverse transcription (rRT)-PCR. Extracted RNAs were screened by targeting the upE region, and positive results were confirmed by a subsequent amplification of orf1a using a PowerChek MERS Real-Time PCR kit (Kogene Biotech, Seoul, South Korea). All rRT-PCR reactions were performed using the 7500 Fast Real-Time PCR System (Applied Biosystems) with a total reaction volume of 20 μL (15 μL of PCR reaction mixture and 5 μL of template RNA). The thermocycling conditions included a reverse transcription reaction for 30 min at 50°C, followed by 10 min at 95°C, and then 40 cycles of 15 sec at 95°C and 60 sec at 60°C. A positive viral template control and a nontemplate control were included in each run. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was amplified simultaneously as an internal control to monitor PCR inhibition. A positive result was identified by a well-defined exponential fluorescence curve that crossed the defined threshold at ≤35 cycles in both the upE and ORF1a assays.
+ Open protocol
+ Expand
2

Autonomous Lab-on-Paper for Multiplex-Gene Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate the clinical utility of the autonomous lab-on-paper platform for multiplex-gene detection, 21 de-identified clinical swab samples (including eight COVID-19 positive samples) were detected. Their viral RNAs were extracted by QIAamp DSP Viral RNA Mini Kit (QIAGEN N.V., Venlo) according to its instruction. 1 μL of RNA extracts was used for multiple detection in the autonomous lab-on-paper platform. After incubation at 37 °C for 40 min, the images of the lab-on-chip platform were taken by the ChemiDoc™ MP Imaging System.
+ Open protocol
+ Expand
3

SARS-CoV-2 Detection by Kaira Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA extraction was performed using QIAamp DSP Viral RNA Mini Kit (Qiagen, Hilden, Germany). The Kaira assay was performed according to the manufacturer’s instructions. In brief, 10 μL of template RNA was added to 12.5 μL of rRT-PCR master mix and 2.5 μL of primer/probe mixture, giving a final reaction volume of 25 μL. The rRT-PCR was performed on the CFX96 system (Bio-Rad, Hercules, CA, USA) using the following cycling conditions: 1 cycle at 50°C for 10 min and 1 cycle at 95°C for 10 min, followed by 45 cycles at 95°C for 10 sec and 57°C for 30 sec. For the SARS-CoV-2 target, a Ct value ≤ 42 was considered a positive result, while for the other three targets, a Ct value ≤ 43 was considered a positive result.
+ Open protocol
+ Expand
4

MERS Clinical Specimen Collection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Institutional Review Board of the Samsung Medical Center, Seoul, Korea, approved this study. For analysis, 100 clinical respiratory specimens (90 sputa and 10 nasopharyngeal swabs) were collected from 100 different individuals from June to July 2015. Fifty specimens were obtained from symptomatic MERS-positive patients, and the remaining 50 were obtained from asymptomatic MERS-negative healthcare workers who were under active monitoring.
Total nucleic acid was extracted by using the QIAamp DSP Viral RNA Mini kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions. A total of 140 µL of specimen was used, and the RNA was eluted in 50 µL and stored at −70℃ until testing with the PowerChek MERS and sequencing assays.
+ Open protocol
+ Expand
5

Norovirus Detection Cross-Reactivity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stool samples positive for the norovirus GII.4 Sydney genotype and the norovirus GI.2 genotype were generously provided by Jan Vinjé from the National Calicivirus Laboratory at the Centers for Disease Control and Prevention (CDC). Escherichia coli MG1655 (ATCC, 700926), methicillin-resistant Staphylococcus aureus MRSA252 (ATCC, BAA-1720) and Bacillus subtilis 168 (ATCC, 23857) were used for assay cross-reactivity experiments. For these experiments, RNA from the bacteria was extracted using a Quick-RNA Fungal/Bacterial Miniprep Kit (Zymo Research) following the manufacturer’s instructions. To obtain purified viral RNA for cross-reactivity experiments, 5 µl of GII.4, GI.2 and GI.6 positive stool samples were suspended in 140 µl RNase-free water. The viral RNA was extracted by using QIAamp DSP Viral RNA Mini Kit (Qiagen, USA) according to the manufacturer’s instructions. RNAs were eluted with 50 µl RNase-free water and stored at −80°C. Escherichiacoli DH5ɑ (ThermoFisher Scientific) was used for cloning of toehold switch plasmids.
+ Open protocol
+ Expand
6

RNA Extraction and RT-qPCR for SARS-CoV-2 Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The QIAamp DSP Viral RNA Mini Kit (#61904) for RNA extraction was purchased from QIAGEN (Hilden, Germany). The SuperScript™ IV One-Step RT-PCR System (#1235820), TaqPath™ 1-Step RT-qPCR Master Mix (4X) (#A15299), nuclease-free water (#4387936), and carrier RNA (#4382878) work as negative control was purchased from Thermo Fisher Scientific Inc. (Waltham, USA). The TwistAmp® Basic kit (#TABAS03KIT) for recombinase polymerase amplification (RPA) was purchased from TwistDx Limited (Maidenhead, UK). EnGen® Lba Cas12a (#M0653T) and NEBuffer™ 2.1 (#B7202S), ProtoScript® II Reverse Transcriptase (#M0368S) were purchased from New England Biolabs (Ipswich, USA). Primers, gRNA, probes (Table S1), including those for the 2019-nCoV CDC qPCR Probe Assay (CDC Emergency Use Authorization Kits, #10006606), and the 2019-nCoV_N_Positive Control (#10006625), Hs_RPP30 Control (#10006626), MERS-CoV Control (#10006624), and SARS-CoV Control (#10006623) were synthesized by Integrated DNA Technologies, Inc. (Coralville, USA).
+ Open protocol
+ Expand
7

SARS-CoV-2 Detection by rRT-PCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nasopharyngeal and oropharyngeal swabs were collected into T-SWAB TRANSPORT UTMs (Noble Biosciences, Korea) and sputum specimens into 50-mL Falcon tubes containing phosphate buffer (Corning Inc., USA). A QIAamp DSP Viral RNA Minikit (Qiagen GmbH, Germany), QIAcube System (Qiagen GmbH), NX-48 Viral NA Kit (Genolution, Korea), and Nextractor NX-48 System (Genolution) were used for RNA extraction according to the manufacturers’ instructions. SARS-CoV-2 nucleic acid was amplified by rRT-PCR using PowerCheck 2019-nCoV Real-time PCR Kits (Kogenebiotech, Korea). The ABI 7500 real-time PCR system (Applied Biosystems, USA) was used to amplify the E and RdRp genes of SARS-CoV-2 (40 cycles). SARS-CoV-2 infection was diagnosed when both genes were detected under 35.0 cycles.
+ Open protocol
+ Expand
8

COVID-19 Diagnostic Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The nasopharyngeal and oropharyngeal
samples were provided by the U2 Clinical Laboratories (Jangwon Medical
Foundation). The viral RNA of the COVID-19 disease was extracted and
purified by using the QIAamp DSP Viral RNA Mini Kit (QIAGEN). The
conventional RT-qPCR tests targeting the E gene, open reading frame
1 (ORF1) gene, and internal control (ribonuclease P; RNaseP) were
performed with a STANDARD M nCoV real-time detection kit (SD Biosensor)
for clinical diagnosis of COVID-19, and the remaining samples were
collected for the clinical diagnostic test of the pRT-qPCR system.
The patient samples and healthy controls are given identification
numbers after a random arrangement and delivered under single-blind
condition. The pRT-qPCR system performed E-gene-targeted clinical
diagnostic tests and internal control on each PoM cartridge.
+ Open protocol
+ Expand
9

SARS-CoV-2 Detection by One-Step RT-qPCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sample processing occurred by extracting nucleic acid using a commercial viral RNA extraction kit (QIAamp DSP Viral RNA Mini Kit, Qiagen, Germantown, MD). The Luna Universal Probe One-step RT–qPCR kit (New England Biolabs, Ipwsich, MA) was then used with standardized primer and probe concentrations of 500 nM of forward and reverse primer, and 250 nM of probe, for the 2019-nCoV_N1, 2019-nCoV_N2, and RP (human control) primer–probe sets to detect SARS-CoV-2 in each sample. PCR cycler conditions were reverse transcription for 10 minutes at 55°C, initial denaturation for 1 minute at 95°C, followed by 45 cycles of 10 seconds at 95°C and 30 seconds at 55°C on CFX Connect Real Time System (Biorad).
Analysis of data was primarily descriptive.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!